Cargando...
Chemotherapy Decisions and Patient Experience with the Recurrence Score Assay for Early-Stage Breast Cancer
BACKGROUND: The 21-gene recurrence score assay (RS) stratifies early-stage, estrogen receptor-positive breast cancer by recurrence risk. Few studies have examined how physicians use RS to recommend adjuvant systemic chemotherapy or patient experiences with testing and decision-making. METHODS: We su...
Gardado en:
| Publicado en: | Cancer |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5161570/ https://ncbi.nlm.nih.gov/pubmed/27775837 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30324 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|